Spinal muscular atrophy (SMA) is a genetic disorder characterized by weakness in muscles and is caused by a loss of specialized nerve cells, called motor neurons, that control muscle movement. Since SMA significantly impacts both the quality of life and lifespan of those affected, this activity will describe the genetic basis for SMA and the various phenotypic expressions as well as improvements in accessing pharmacologic treatments for SMA.